Haemodialysis-associated amyloidosis
| Haemodialysis-associated amyloidosis | |
| ICD-10 | E85.3 |
|---|---|
| ICD-9 | 277.3 |
| eMedicine | med/3384 |
Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.[1]
Presentation
Long term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood. It accumulates because it is unable to cross the dialysis filter.
Prevention
Low copper dialysis is theorized to prevent or delay onset.[2]
References
- ↑ Miyata T, Oda O, Inagi R, et al (September 1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMID 8376584.
- ↑ BU.
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Haemodialysis-associated amyloidosis On the Web |
|
American Roentgen Ray Society Images of Haemodialysis-associated amyloidosis |
|
Risk calculators and risk factors for Haemodialysis-associated amyloidosis |
